OTCPK:MEDVF - Post by User
Post by
Sarb99on Sep 24, 2020 2:26am
1008 Views
Post# 31609750
home-based collection of finger prik blood and saliva test
home-based collection of finger prik blood and saliva testSeems like QuestCap is part of this study proposing to assess the occurrence of antibodies to COVID-19 as well as test for current presence of virus using home-based collection of finger pr ick blood and saliva. The study is intended to run for 6 months with blood collection every 2 months and saliva collection every 2 weeks.
https://www.lunenfeld.ca/shawl/
SHAWL Study Information Page SHAWL-1 (Stay-Healthy-At-Work-Lunenfeld): Occurrence of serological positivity of SARS-CoV-2 reactive antibodies and of salivary SARS-CoV-2 RNA in the LTRI/Sinai workforce over time | Principal Investigator and Lead Scientist | Dr. Anne-Claude Gingras | | Clinical Investigator | Dr. Pamela Goodwin | | Co-Investigators | Dr. Rod Bremner
Dr. Jeff Wrana
Dr. Jim Woodgett
Dr. Rita Kandel
Dr. Tony Mazzulli
Dr. Keith Jarvi | | Sponsor | Sinai Health & LTRI (Sinai Health Foundation funding) | Drs. Anne-Claude Gingras and Pamela Goodwin are leading a new study to evaluate the prevalence of COVID-19 among defined cohorts of otherwise asymptomatic people. Using technology developed here by the labs of Drs. Gingras, Bremner and Wrana, they are proposing to assess the occurrence of antibodies to COVID-19 as well as test for current presence of virus using home-based collection of finger pric k blood and saliva. The study is intended to run for 6 months with blood collection every 2 months and saliva collection every 2 weeks. Although we encourage all participants to perform self-collection of blood samples, we will offer venipuncture for those who are unwilling or unable to perform self-collection for all or a portion of the blood samples. We would like to invite you to participate in this study. Participation is entirely voluntary and your decision to participate or not will not have any impact on your current or future employment or academic status at LTRI/Sinai Health or on your relationships with or care at Sinai Health. If you are found to have a positive saliva test, you will be required to self-isolate and attend a COVID assessment center for further evaluation and employees will be required to be cleared by Occupational health and Safety prior to return to work. The identity of subjects is not known to the study scientists, with the exception of Dr. Goodwin, and only in case of a positive saliva test, where the participant will be contacted and referred to a COVID Assessment Center and Occupational Health for a re-test. The results of all tests will be made available to participants if they wish to receive them. Further details and instructions for those who are interested in learning more about the study can be found at https://www.lunenfeld.ca/shawl. To review the study consent form please click on this link shawl.lunenfeld.ca. If you have any questions about the study, you can contact the study administration team at shawl@lunenfeld.ca or Linda Bennett (416-586-4800, ext. 2426 or cell: 647-885-0952). Best wishes and stay safe, Jim Woodgett Note: The link shawl.lunenfeld.ca requires use of a computer or device connected to the LTRI computer network. Two workstations are available in room 1062 (10th floor, Murray St Wing) for those wishing to register but who don’t have access to the research network. Once registered for the study, password protected access can be achieved from anywhere.
| |